University of Colorado Cancer Center
Anschutz Cancer Pavilion
Aurora, CO
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Accepting patients
CAMMA-2
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2)
Learn more- Bispecific Antibody
- FCRH5
- Phase 1/2
Accepting patients
CaMMouflage
A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage Trial)
Learn more- CAR T Cell (Allogeneic)
- BCMA
- Phase 1
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
Early Detection Blood Tests
Blinded Reference Set for Multicancer Early Detection Blood Tests
Learn more- Observational Trial
Accepting patients
Aging Assessment
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Learn more- Closed Label (Masked)
- Randomization
Not currently accepting
Cevostamab
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- FCRH5
- Phase 1
- Has results
Accepting patients
Investigational Cord Blood Units
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program (NCBP) for Unrelated Transplantation
Learn more- Allogeneic Stem Cell Transplant
- Phase 2